Are you Dr. Munn?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1120 15th St
Augusta, GA 30912Phone+1 706-721-3626Fax+1 706-721-2643
Summary
- Dr. David Munn, MD is a pediatric hematologist/oncologist in Augusta, Georgia. He is currently licensed to practice medicine in Georgia. He is a Professor at Medical College of Georgia at Georgia Health Sciences University.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1987 - 1990
- Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1984 - 1987
- Medical College of Georgia at Augusta UniversityClass of 1984
Certifications & Licensure
- GA State Medical License 1990 - 2015
Publications & Presentations
PubMed
- 70 citationsEffects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primatesDavid H. Munn, Marc B. Garnick, Nai-Kong V. Cheung
Blood. 1990-05-15 - 71 citationsHost Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor ToleranceTheodore S. Johnson, David H. Munn
Immunological Investigations. 2012-09-27 - 279 citationsCells Expressing Indoleamine 2,3-Dioxygenase Inhibit T Cell ResponsesAndrew L. Mellor, Derin B. Keskin, Theodore S. Johnson, Phillip Chandler, David H. Munn
Journal of Immunology. 2002-04-15
Press Mentions
- Novel Immunotherapy Beneficial to Children with Relapsed Brain Tumours: ResearchApril 25th, 2023
- Novel Treatment Regimen Appears Well Tolerated, Beneficial to Children with Relapsed Brain TumorsApril 25th, 2023
- Loss of Indoleamine-2,3-Dioxygenase-1 (IDO1) in Knockout Mice Does Not Affect the Development of Skin Lesions in the Imiquimod-Induced Mouse Model of PsoriasisFebruary 28th, 2022
- Join now to see all
Grant Support
- Ido-Mediated Immune Regulation In Established TumorsNational Cancer Institute2010–2012
- Role Of IDO MalignancyNational Cancer Institute2010–2011
- Ido-Expressing Immunoregulatory Dendritic CellsNational Cancer Institute2010–2011
- Role Of IDO MalignancyNational Cancer Institute2007–2009
- Ido-Expressing Plasmacytoid Dendritic Cells And TumorsNational Cancer Institute2005–2009
- Ido-Expressing Immunoregulatory Dendritic CellsNational Cancer Institute2003–2009
- Role Of IDO In MalignancyNational Cancer Institute2003–2006
- Macrophage Mediated Immunoregulation VIA TryptophanNational Heart, Lung, And Blood Institute1999–2002
- Inhibition Of T Cells By Tryptophan DegradationNational Institute Of Allergy And Infectious Diseases1998–1999
- Regulation Of Macrophage ApoptosisNational Heart, Lung, And Blood Institute1995–1997